Price Prediction: Rocket Lab Will Hit $150 on This Date

Photo of Vandita Jadeja
By Vandita Jadeja Published

Quick Read

  • RKLB surged 309% over the past year, earns a BUY rating with a $117 base target, and could cross $150 by April 2027.

  • Q1 revenue hit $200M, up 63% year-over-year, and backlog reached a record $2.2B, yet the stock pulled back 18% from its highs.

  • Bears cite 100x price-to-sales, $450M in dilutive raises, and a Neutron delay that could push RKLB toward the $89 bear-case target.

  • Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and Rocket Lab didn't make the cut. Grab the names FREE today.

Price Prediction: Rocket Lab Will Hit $150 on This Date

© ImageFlow / Shutterstock.com

Rocket Lab (NASDAQ:RKLB | RKLB Price Prediction) trades at $107.98, up 308.71% over the past year. Our 24/7 Wall St. price target for Rocket Lab is $116.77 over the next 12 months, implying 8.14% upside from here.

Under our bull case, the stock crosses the $150 threshold on April 18, 2027, when the model projects RKLB at $149.33. Our recommendation is buy, with moderate confidence.

RKLB price target

24/7 Wall St. Price Target Summary

Metric Value
Current Price $107.98
24/7 Wall St. Price Target $116.77
Upside 8.14%
Recommendation BUY
Confidence Level 50%
Bull Case $150 Date April 18, 2027

A Record Quarter and a 17% Pullback

Rocket Lab has been one of the most volatile names in the market. Shares are up 54.79% year to date, yet down 17.67% over the past month after peaking near the $151 52-week high.

The pullback came despite Q1 FY26 results that crushed expectations: revenue of $200.35 million, up 63.5% YoY and beating consensus by 5.77%, with non-GAAP gross margin expanding to 43% from 33.4%. Backlog hit a record $2.20 billion, and Rocket Lab signed 31 new Electron and HASTE contracts plus 5 dedicated Neutron missions. 

RKLB earnings explorer
An infographic titled 'Rocket Lab USA Inc. RKLB 12-Month Price Prediction' on a dark green background with a subtle grid pattern. The 'The Call' section displays the current price of $107.98 (June 18, 2026), a 'BUY' recommendation, a price target of $116.77, and an 8.14% upside with a moderate confidence level. The 'How We Got There' section shows trailing and forward P/E-based prices as $0 (Excluded) and an analyst consensus target of $107.03, leading to a weighted base price of $107.03. The 'Our Adjustments' section lists factors like 247Factor Adjustment (1.091, 9.1% Lift), Sector Momentum (Industrials) (+1.05x), Analyst Consensus (78% Bullish) (+0.047), Social Sentiment (Positive Retail) (+0.013), Volatility (Beta 2.5) (-0.03), and Large-Cap Dampener (Applied), all contributing to the final price target of $116.77. The 'Bull Case: What Could Go Right' section, highlighted in a lighter green, lists Neutron Debut Launch (Later in 2026), Space-Based Interceptor Program, $2.20 Billion Record Backlog, and Strong Analyst Ratings (14 Buy/Strong Buy), with a bull case target of $155.14 (Crossing $150 on April 18, 2027). The 'Bear Case: What Could Go Wrong' section, highlighted in red, lists Neutron Execution Risk (Delayed to Q4 2026), Equity Dilution ($450M ATM in Q1), Stretched Valuation (P/S 100x), and Unprofitable & Negative Cash Flow, with a bear case target of $89.26 (-17% Drawdown). The bottom section, 'THE BOTTOM LINE', reiterates '[BUY] ROCKET LAB (RKLB) -> $116.77 (+8.14%)' and notes the $150 milestone is achievable in the bull scenario by April 2027.
24/7 Wall St.

The Case for $150 and Beyond

Our bull case targets $155.14 within one year, with the $150 milestone crossed on April 18, 2027. The catalysts are tangible. The Neutron debut launch is on track for later in 2026, opening medium-lift revenue.

Rocket Lab was selected for the Department of War’s Space-Based Interceptor program under Golden Dome with Raytheon, and the $816 million SDA Tranche 3 contract remains the largest in company history.

CEO Peter Beck framed the quarter bluntly: “We’ve blown through the ceilings across all of the most important metrics.” Of 18 covering analysts, 14 rate it Buy or Strong Buy, with zero sells.

What Could Go Wrong

The bear case lands at $89.26, a 17% drawdown. The risks are real: Neutron’s stage 1 tank test failure already pushed first launch to Q4 2026, and any further slip would damage credibility.

Rocket Lab raised $450 million through an ATM in Q1 alone, adding meaningful dilution. The valuation is also stretched at a price-to-sales of 100x. Polymarket traders see the highest probability for June ending at $136 with only 7.5% odds on $152.

That said, bulls would counter that heavy stock-based comp and ATM raises are funding genuine vertical-integration assets (Mynaric, Motiv, Geost) rather than burning on operations.

Rocket Lab Price Prediction 2026-2030

The bull thesis at $107.98 hinges on Neutron flying on schedule and the Golden Dome opportunity scaling. The setup weakens if Neutron slips into 2027 or if the next ATM lands at a lower price. The 24/7 Wall St. price target of $116.77 is the base case; the path to $150 by April 18, 2027 depends on clean execution.

Year 24/7 Wall St. Price Target
2026 $116.77
2027 $125
2028 $132
2029 $140
2030 $147.55

These projections assume Rocket Lab continues executing on Neutron, SDA, and Golden Dome. Significant upside could result from full Neutron reusability by 2028, while a hardware setback would compress the path.

Photo of Vandita Jadeja
About the Author Vandita Jadeja →

Vandita Jadeja is a financial copywriter who loves to read and write about stocks. She believes in buying and holding for long term gains. Her knowledge of words and numbers helps her write clear stock analysis. She has contributed to several publications, including the Joy Wallet, Benzinga, The Motley Fool and InvestorPlace.

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.

Continue Reading

Top Gaining Stocks

KMX Vol: 7,330,419
GLW Vol: 22,800,969
INTC Vol: 233,719,006
SMCI Vol: 68,465,534
ENPH Vol: 13,978,376

Top Losing Stocks

ACN Vol: 41,744,333
EPAM Vol: 5,636,587
CTSH Vol: 61,311,400
CTRA Vol: 73,319,495
KR Vol: 26,704,230